Friday, February 11, 2005
Dorr Joins Nereus Pharmaceuticals
San Diego-based Nereus Pharmaceuticals has added F. Andrew Dorr to the company as Chief Medical Officer and SVP of Clinical Development and Regulatory Affairs. Dorr was most recently COO at Salmedix, and CMO and VP Drug Development at Isis Phramaceuticals. Nereus is a drug discovery an development company focusing on anticancer compounds and anti-infectives.